je.st
news
Home
› Actavis to spend $66 billion on Allerganvisit|article-5898166|mobile_home_category_body-6916|6
Actavis to spend $66 billion on Allerganvisit|article-5898166|mobile_home_category_body-6916|6
2014-11-19 00:38:31| Biotech - Topix.net
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products. CEO Brent Saunders said Monday that the combined company will have more than two dozen products in late-stage clinical testing, which is usually the last and most expensive development phase, and it will work to support research.
Tags: spend
billion
actavis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||